{
    "medicine_id": "d530a1a72b045602e2730ec3bbbe4e6d40aa0744",
    "platform_id": "DB11160",
    "metadata": {
        "name": "Ali flex 30 mg Capsule",
        "composition": "30 mg Phenyltoloxamine",
        "clinical_particulars": {
            "therapeutic_indications": "The primary therapeutic use for which phenyltoloxamine is currently indicated is as an adjuvant therapy in various combination products containing an analgesic s either narcotic or non narcotic where it is expected to potentiate the pain relieving anti tussive etc effect s of the analgesic component of the product In that regard some of these aforementioned combination products are typically indicated for the temporary relief of minor aches and pains like headache muscular aches backaches minor arthritis pain common cold toothaches menstrual cramps etc L2499 or perhaps for the treatment of exhausting or non productive cough associated with cold or with upper respiratory allergic condition that does not respond to non narcotic antitussives L2495",
            "contraindications": {
                "disease": "Toxicity after overdose may involve CNS effects like extreme drowsiness lethargy confusion delirium and coma in adults paradoxical excitation irritability hyperactivity insomnia hallucinations seizures and respiratory depression or arrest in infants and young children CNS adverse effects predominate o er cardiac adverse effects death may occur within hours after ingestion of drug in untreated patients rhabdomyolysis has also been reported A32705",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "As a member of the first generation H1 antihistamines it is known that phenyltoloxamine like virtually all first generation H1 antihistamines has a propensity for crossing the blood brain barrier and acting on H1 histamine receptors there to interfere with neurotransmission A32705 The most common results of this kind of first generation H1 antihistamine CNS neurotransmission interference are adverse effects like drowsiness sedation somnolence and fatigue A32705 Given these effects under specific circumstances like a patient experiencing a pain or a cough that may be preoccupying all of their waking energy and attention it is perhaps possible that the sedative and tranquilizing characteristics of phenyltoloxamine may be the factors that contribute to its apparent adjunctive analgesic A32708 A32709 and antitussive actions L2495 A32707",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}